Vaxart Second Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Vaxart, Inc. (VXRT)
Last vaxart, inc. earnings: 3/19 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Net loss: US$16.5m (loss narrowed by 27% from 2Q 2023). US$0.089 loss per share (improved from US$0.16 loss in 2Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Vaxart Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 71%. Earnings per share (EPS) also missed analyst estimates. Looking ahead, revenue is forecast to grow 50% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are down 6.5% from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 3 warning signs for Vaxart you should be aware of, and 1 of them is significant. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provid
Show less
Read more
Impact Snapshot
Event Time:
VXRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VXRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VXRT alerts
High impacting Vaxart, Inc. news events
Weekly update
A roundup of the hottest topics
VXRT
News
- Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical DysplasiaGlobeNewswire
- Oppenheimer starts Vaxart at outperform, cites oral vaccine focus [Seeking Alpha]Seeking Alpha
- Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside [Yahoo! Finance]Yahoo! Finance
- Vaxart, Inc. (NASDAQ: VXRT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $4.00 price target on the stock.MarketBeat
VXRT
Earnings
- 8/8/24 - Miss
VXRT
Sec Filings
- 8/8/24 - Form 10-Q
- 8/8/24 - Form 8-K
- 7/5/24 - Form 8-K
- VXRT's page on the SEC website